For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
New FDA lab tests rule could bankrupt small labs
Yesterday the Food and Drug Administration (FDA) announced that on May 6 it will promulgate a rule under its authority to regulate medical devices.
National Review
The Return of the Cadillac Tax?
Like the phoenix, a key piece of the Affordable Care Act has risen from the ashes, resurrected, believe it or not, by the Republican Study Committee…
Blog
Free the Economy podcast: Paying for organs with Pete Jaworski
In this week’s episode we cover the future of AI and employment, why we shouldn’t trust Chinese economic statistics, and how the…
Search Posts
Blog
New FDA lab tests rule could bankrupt small labs
Yesterday the Food and Drug Administration (FDA) announced that on May 6 it will promulgate a rule under its authority to regulate medical devices.
National Review
The Return of the Cadillac Tax?
Like the phoenix, a key piece of the Affordable Care Act has risen from the ashes, resurrected, believe it or not, by the Republican Study Committee…
Blog
Free the Economy podcast: Paying for organs with Pete Jaworski
In this week’s episode we cover the future of AI and employment, why we shouldn’t trust Chinese economic statistics, and how the…
City Journal
A Solution in Search of a Problem
In his State of the Union address, President Biden touted the drug-price controls in his Inflation Reduction Act (IRA). Though the price controls have yet…
Blog
This week in ridiculous regulations: Taconite and lab fees
President Biden delivered his State of the Union address. Super Tuesday primaries all but settled this year’s presidential combatants. The FTC has a full slate…
National Review
Covid Vaccines: An Update on Balancing Risks and Benefits
A new large, multi-country study has confirmed what previous smaller studies found: Covid-19 vaccines have risks. In particular, the messenger RNA (mRNA) vaccines from Pfizer and…
City Journal
Ignoring the Science
A new CDC study reports that the first updated Covid-19 vaccine—the bivalent vaccine approved in fall 2022—was about 50 percent effective in blocking infection over a two-month…
The Federalist Society
Explainer 62 – FDA’s Regulation of Laboratory Developed Tests
CEI’s Joel Zinberg joined a podcast hosted by The Federalist Society for the Regulatory Transparency Project on the FDA’s regulation of laboratory developed tests:…
National Review
When Science Is Not Science
Just 22 percent of all adults and 41 percent of those 65 and older — the most vulnerable group — have received the updated 2023–24 Covid-19 vaccine.
Blog
When the FTC’s anti-merger goals overshadow the prospect of saving lives
The Fifth Circuit Court of Appeals recently issued a ruling on the important case of Illumina-Grail v. Federal Trade Commission. A unanimous 3-0…
Beritbart
Unholy Alliance Between the Left and Big Pharma Threatens More Big Government Intervention in Health Care
CEI’s Joel Zinberg is cited in Breitbart on the big government intervention in healthcare: Economic experts recognize that the very foundation of a free…
City Journal
A “Coordinated Campaign”
The Covid-19 pandemic revealed a split between those who believe that the government has broad authority to control every aspect of the economy and society…
Washington Times
Cutting-edge drugs could vanish under Biden’s unprecedented move to seize patents
CEI’s Dr. Joel Zinberg is cited in the Washington Times on the Biden Administration’s move to seize patents: Dr. Joel Zinberg, a senior fellow…
National Review
Another FDA Power Grab
The comment period for the Food and Drug Administration’s latest power grab has just concluded. Roughly 20,000 comments were submitted addressing the FDA’s proposed rule which…
Comment
Comments RE: Docket No. FDA–2023–N–2177 for “Medical Devices; Laboratory Developed Tests
I am an attorney with the Competitive Enterprise Institute. The Competitive Enterprise Institute is a non-profit research and advocacy organization that focuses on regulatory policy.
Washington Times
Better late than never: New York Times finally admits school shutdowns hurt children
The New York Times has made a “startling” discovery. Its editorial board has recognized that “school closures that took 50 million children out of classrooms…
City Journal
Not-So-Affordable Care
In a 2022 book, Seemed Like a Good Idea, health economist Mark Pauly and his University of Pennsylvania coauthors describe how health-care policymakers “often rely on…
News Release
CEI leads coalition calling on Congress to repeal drug price control provisions of the Inflation Reduction Act
The Competitive Enterprise Institute (CEI) and a coalition 43 conservative and free market groups sent a letter to Congress today calling for the…
Letters
Coalition Letter to End IRA Prescription Drug Price Controls
October 31, 2023 Dear Members of Congress, When the Inflation Reduction Act was passed and signed into law a year ago, the legislation granted the…
Blog
This week in ridiculous regulations: Blood donations to mortality tables
Poland voted its nationalist-populist government out of power. The US House of Representatives remained without a speaker, but with a lot of drama. Agencies issued…
City Journal
Equity vs. Evidence
The U.S. Preventive Services Task Force—a volunteer panel of national experts in prevention and evidence-based medicine that makes recommendations for clinical preventive services such as…
National Review
Restricting Pharmacy Benefit Managers Could Decrease Competition and Increase Drug Costs
Congress is considering multiple bills that aim to restrict the ability of pharmacy benefit managers (PBMs) to negotiate discounts and rebates and to require the PBMs…
PCMA
Just the Facts: Research and Analysis Finds Anti-PBM Legislation Does Not Lower Prescription Drug Costs for Patients
PCMA cites CEI’s Joel Zinberg anti PBM legislation: “This policy would significantly change drug pricing and utilization and shift billions of dollars annually from patients…
Wall Street Journal
Court to FDA: Stop Playing Doctor
The Food and Drug Administration regulates pharmaceuticals, but it has no business playing doctor and giving you medical advice. That’s the message of a Sept.
News Release
Congressional Efforts to Regulate PBMs Risk Higher Drug Costs, Worse Health Outcomes for Patients
Pharmacy Benefit Managers (PBMs) are private businesses that developed in the free market to manage prescription drug benefits for health insurance plan sponsors. Nearly all…
Study
A Free Market Solution for Drug Distribution
Executive summary This paper describes and explains the function of Pharmacy Benefit Managers (PBMs) in the American health care economy. PBMs are private businesses that…
New York Post
Djokovic can compete in the US Open again — after Biden finally ended his unscientific travel ban
The US Open tennis tournament has begun in Queens, and one of the world’s best players will finally be allowed to compete again. Novak…
New York Post
Don’t believe doomsayers — new COVID outbreak is mild, and masks don’t help
COVID-19 cases are expected to rise this fall as new variants become more prevalent. And, as unfortunately expected, it’s already triggered demands by…
Fox News
New report reveals how CDC can be ready for the next pandemic
The Centers for Disease Control and Prevention has a new director, Dr. Mandy Cohen. Her predecessor, Dr. Rochelle Walensky, acknowledged CDC was…
Citation
Dr. Joel Zinberg discusses his report on refocusing and reforming the CDC after COVID-19 on C-SPAN’s Washington Journal
CEI Senior Fellow Joel Zinberg joined Washington Journal on August 11, 2023 to discuss new study from CEI and Paragon Health Institute which found…
News Release
New Study from CEI and Paragon Health Institute finds CDC shortcomings and recommends key reforms
The Competitive Enterprise Institute (CEI) and the Paragon Health Institute published a new paper today by CEI senior fellow and director of…
Study
Unauthorized and Unprepared: Refocusing the CDC after COVID-19
Executive Summary What This Paper Covers The Centers for Disease Control and Prevention, the nation’s preeminent public health agency, has acknowledged that it failed badly…
Blog
This week in ridiculous regulations: soybean standards and pain medication limits
The FTC issued its new draft merger guidelines. Meanwhile, agencies issued new regulations ranging from milk marketing to Postal Service snitches. On to the…
New York Post
Memo to critics: Only folks who don’t qualify will lose their Medicaid
Medicaid advocates are demanding the federal government to stop states from removing people from the program after 25 states and the District of Columbia dropped…
City Journal
Lab Leak: Likely
Three previously unreleased State Department cables, obtained by the public-health group U.S. Right to Know through a Freedom of Information Act lawsuit, confirm…
Washington Examiner
The Biden administration shouldn’t waste more taxpayer dollars on COVID vaccines
A Food and Drug Administration advisory committee recently voted to recommend updating the COVID-19 vaccine. But important questions remain: When…
Letters
CEI Joins Coalition Letter Supporting Efforts to Stop Tobacco Prohibitions in Ag Approps Bill
Chairwoman Granger and Ranking Member DeLauro, The undersigned organizations representing millions of consumers and taxpayers support Sections 768 and 769 of the Fiscal Year 2024…
National Review
Pharmaceuticals: Marching into Trouble
The National Institutes of Health recently rejected a request by private petitioners to exercise “march-in rights” under the 1980 Bayh-Dole Act to control the…
City Journal
Nature’s Vaccine
Public-health officials in the U.S., unlike their counterparts elsewhere, have steadfastly focused on Covid-19 vaccines in fighting the pandemic, acting as if natural immunity following…
Washington Examiner
Under Walensky, the CDC has destroyed public trust in its credibility
The White House announced last week that Dr. Rochelle Walensky will be leaving her post as director of the Centers for Disease Control and Prevention. She…
Wall Street Journal
Don’t Let Unspent Covid Funds Become Slush Funds
The House has passed the Limit, Save, Grow Act, which would raise the debt limit for a year in exchange for deficit-relief measures. One of…
National Review
No, Lockdown States Did Not Do Better
Many politicians, public-health figures, and media pundits continue to insist that the Covid lockdowns were a success and represent a blueprint for future pandemic responses. Illinois…
City Journal
Roll It Back
Medicaid, the federal-state entitlement for the poor, now provides health insurance to more than one in four Americans. Enrollments surged after the Affordable Care Act…
City Journal
Politically Correct Medical Scholarship Doesn’t Help Blacks
A recent article in the British Medical Journal, “Inequities in surgical outcomes by race and sex in the United States,” is important—not…
National Review
Was the U.S. furtively funding the lab research that unleashed Covid-19?
Slowly but surely, new cracks are appearing in the wall of silence denying Chinese culpability in causing the nearly 7 million deaths attributed to…
Blog
Covid Lockdowns Did Not Improve Outcomes: Lessons from Florida and California
My Competitive Enterprise Institute colleague Dr. Joel Zinberg is the co-author of a new report, published by the Paragon Health Institute titled “Freedom Wins:…
The Center Square
Fauci takes heat after casting doubt on efficacy of COVID vaccines
CEI’s Joel Zinberg is cited in The Center Square on COVID vaccines: Joel Zinberg, a Competitive Enterprise Institute senior fellow, blasted Fauci for pushing for…
The Washington Journal
VIDEO: Joel Zinberg Joins the Washington Journal
Dr. Joel Zinberg joins the Washington Journal to discuss the efficacy of COVID lockdowns and government restrictions as they relate to public health and take…
The Washington Journal
Video: Dr. Joel Zinberg Joins the Washington Journal to Discuss COVID Lockdowns
Dr. Joel Zinberg joins the Washington Journal to discuss the efficacy of COVID lockdowns and government restrictions as they relate to public health and take…
National Review
Fauci Changes His Public Tune on Covid Vaccines
Dr. Anthony Fauci has finally acknowledged that there had always been good scientific reasons to believe that vaccines against the respiratory…